BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 7812956)

  • 1. Correlation of the in situ detection of polymerase chain reaction-amplified metalloproteinase complementary DNAs and their inhibitors with prognosis in cervical carcinoma.
    Nuovo GJ; MacConnell PB; Simsir A; Valea F; French DL
    Cancer Res; 1995 Jan; 55(2):267-75. PubMed ID: 7812956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of metalloproteinase 2 and 9 and their inhibitors in renal cell carcinoma.
    Kugler A; Hemmerlein B; Thelen P; Kallerhoff M; Radzun HJ; Ringert RH
    J Urol; 1998 Nov; 160(5):1914-8. PubMed ID: 9783985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression and activation of matrix metalloproteinase-2 (MMP-2) and its co-localization with membrane-type 1 matrix metalloproteinase (MT1-MMP) correlate with melanoma progression.
    Hofmann UB; Westphal JR; Zendman AJ; Becker JC; Ruiter DJ; van Muijen GN
    J Pathol; 2000 Jul; 191(3):245-56. PubMed ID: 10878545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic values of matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 expression in bladder cancer.
    Kanayama H; Yokota K; Kurokawa Y; Murakami Y; Nishitani M; Kagawa S
    Cancer; 1998 Apr; 82(7):1359-66. PubMed ID: 9529029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High levels of tissue inhibitor of metalloproteinase-2 (TIMP-2) expression are associated with poor outcome in invasive bladder cancer.
    Grignon DJ; Sakr W; Toth M; Ravery V; Angulo J; Shamsa F; Pontes JE; Crissman JC; Fridman R
    Cancer Res; 1996 Apr; 56(7):1654-9. PubMed ID: 8603416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemical detection of matrix metalloproteinases (MMP) 1 and 2, and tissue inhibitor of metalloproteinase 2 (TIMP 2) in stage I and II endometrial cancer.
    Moser PL; Hefler L; Tempfer C; Neunteufel W; Kieback DG; Gitsch G
    Anticancer Res; 1999; 19(3B):2365-7. PubMed ID: 10472357
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of proteinases and proteinase inhibitors during embryo-uterine contact in the pig.
    Menino AR; Hogan A; Schultz GA; Novak S; Dixon W; Foxcroft GH
    Dev Genet; 1997; 21(1):68-74. PubMed ID: 9291582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression and in-situ localization of genes coding for extracellular matrix proteins and extracellular matrix degrading proteases in pancreatic cancer.
    Gress TM; Müller-Pillasch F; Lerch MM; Friess H; Büchler M; Adler G
    Int J Cancer; 1995 Aug; 62(4):407-13. PubMed ID: 7635566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reverse transcription-polymerase chain reaction phenotyping of metalloproteinases and inhibitors involved in tumor matrix invasion.
    Onisto M; Garbisa S; Caenazzo C; Freda MP; Di Francesco C; Nitti D; Liotta LA; Stetler-Stevenson WG
    Diagn Mol Pathol; 1993 Jun; 2(2):74-80. PubMed ID: 8269280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of immunoreactive matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in human normal livers and primary liver tumors.
    Terada T; Okada Y; Nakanuma Y
    Hepatology; 1996 Jun; 23(6):1341-4. PubMed ID: 8675149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of matrix metalloproteinases (MMP-2 and -9) and tissue inhibitors of metalloproteinases (TIMP-1 and -2) in acute myelogenous leukaemia blasts: comparison with normal bone marrow cells.
    Janowska-Wieczorek A; Marquez LA; Matsuzaki A; Hashmi HR; Larratt LM; Boshkov LM; Turner AR; Zhang MC; Edwards DR; Kossakowska AE
    Br J Haematol; 1999 May; 105(2):402-11. PubMed ID: 10233411
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunoassays of the metalloproteinase (MMP-2) and tissue inhibitor of metalloproteinase (TIMP 1 and 2) levels in noninvasive and metastatic PC-3 clones: effects of taxol.
    Stearns ME; Wang M
    Oncol Res; 1994; 6(4-5):195-201. PubMed ID: 7841542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytokine regulation of the matrix metalloproteinases and their inhibitors in human papillomavirus-18 transformed human prostatic tumor cell lines.
    Wang M; Fudge K; Rhim JS; Stearns ME
    Oncol Res; 1996; 8(7-8):303-15. PubMed ID: 8938794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Expression and clinical significance of MMP-2, MMP-9,TIMP-1, and TIMP-2 in breast carcinoma].
    Fan SQ; Wei QY; Li MR; Zhang LQ; Liang QC
    Ai Zheng; 2003 Sep; 22(9):968-73. PubMed ID: 12969531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Expression of matrix metalloproteinases-9,2,7,and tissue inhibitor of metalloproteinases-1,2,3 mRNA in ovarian tumors and their clinical significance].
    Hu XX; Li L; Li DR; Zhang W; Cheng XQ; Zhang JQ; Tang BJ
    Ai Zheng; 2004 Oct; 23(10):1194-8. PubMed ID: 15473934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Matrix metalloproteinases in human melanoma cell lines and xenografts: increased expression of activated matrix metalloproteinase-2 (MMP-2) correlates with melanoma progression.
    Hofmann UB; Westphal JR; Waas ET; Zendman AJ; Cornelissen IM; Ruiter DJ; van Muijen GN
    Br J Cancer; 1999 Nov; 81(5):774-82. PubMed ID: 10555745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression and localization of matrix metalloproteinases (MT1-MMP, MMP-2) and tissue inhibitor of metalloproteinase-2 (TIMP-2) during synepitheliochorial placentation of goats (Capra hircus).
    Uekita T; Yamanouchi K; Sato H; Tojo H; Seiki M; Tachi C
    Placenta; 2004 Nov; 25(10):810-9. PubMed ID: 15451196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Expression of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in the hepatocellular carcinomas].
    Wei QY; Wu YQ; Fan SQ
    Hunan Yi Ke Da Xue Xue Bao; 2003 Jun; 28(3):212-6. PubMed ID: 14653069
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Significance of matrix metalloproteinases and tissue inhibitors of metalloproteinase expression in the recurrence of superficial transitional cell carcinoma of the bladder.
    Hara I; Miyake H; Hara S; Arakawa S; Kamidono S
    J Urol; 2001 May; 165(5):1769-72. PubMed ID: 11342973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of matrix metalloproteinase -2, -9 and tissue inhibitors of metalloproteinase -1, -2, -3 mRNAs in rat uterus during early pregnancy.
    Zhao YG; Xiao AZ; Cao XM; Zhu C
    Mol Reprod Dev; 2002 Jun; 62(2):149-58. PubMed ID: 11984824
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.